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Considering the breadth of medicines available without 
a prescription and the spectrum of problems that can 
arise with medication use, pharmacists, particularly those 
working in community pharmacies, have the potential to 
make a huge impact on society. Pharmacy like other health 
professions, has its own codes of ethics for practice, often 
focused at individual country level.  The ownership of such 
codes is very often internal (where professional bodies 
regulate their own ethics)e.g. Jordan, but may also be 
external (where statutory bodies regulate professions) e.g. 
UK. Such enforced codes of practice must be followed, not 
only to safeguard the patient and public but also to preserve 
the integrity of the profession. Nevertheless, violations in 
practice and ethical standards do happen for many reasons. 
An important problem that can raise many ethical issuesand 
practice challenges is prescription/nonprescription 
drug misuse and abuse.[1] This problem is prevailing and 
escalating.[2] Lately, in some Middle Eastern and North 
Africa (MENA) region countries, the political situation, 
security issues and closure of borders had led to shortages 
of illicit drug supplies.[3] With this has come a shift to seek 
licit and available alternatives from community pharmacies 
like ophthalmic drugs,[4] pregabalin[5] or oral hypoglycemic 
agents.[6] In some countries like Jordan,[7] Egypt,[8] Kuwait,[9] 
and Palestine,[10] addiction is seen to shift from one form of 
medicine or drug to another and the potential is high for 
escalation of prevalence.[11] The main challenges community 
pharmacists are facing when dealing with addiction to 
prescription/non-prescription medicines in MENA region 
countries are: lack of robust legislation, outdated drug 
classification, and weaknesses in the pharmacy inspection 
systems. If these factors are not addressed, we predict a 
continuing rise in prescription/non-prescription medicine 
addiction. 
Although drug classification and laws pertaining to drug 
dispensing in many countries of the MENAregion are 
similar to those of the West, these laws are not strictly 
enforced in community pharmacies in many countries. 
This contributes to the problem of prescription/non-
prescription drug misuse/abuse. Apatient can buy any 
medication without a prescription, with the exception 
of controlled narcotics and major tranquilizers (e.g., 
benzodiazepines), which can only be dispensed after 
receipt of a prescription signed by a registered physician.
[9,12] Such uncontrolled consumption and monitoring 
of consumption of is one reason of confusion among 
medications. It also paves the way for some pharmacists 
to behave unethically and sell medications-that are liable 
for abuse- without prescription.  For example, according 
to the Jordanian Drug and Pharmacy Practice Law (2013), 
inspectors from the Jordan Food and Drug Administration 
(JFDA) frequently visit community pharmacies to check 
any violation in general and check special prescriptions for 
medicines, such as opioids, opioid derivatives, or opioid 
containing preparations classified as Schedules 1–8 drugs. 
The pharmacist is required to keep a record of these special 
prescriptions and supply against them, for JFDA inspection. 
As such, it is a rare incidence for a community pharmacy to 
sell schedule 1-8products[13] However, some prescription-
only-medicines that are liable for abuse are not scheduled yet 
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in many countries (e.g. pregabalin, performance enhancing 
hormones, some anticholinergic drugs).This aborts the 
chance to trace any violation and allows some pharmacists 
to sell such preparations without a prescription.
Moreover, in community pharmacy, especially in climates 
of financial crisis,patient care aspects of practice can appear 
less relevant and very divorced from business aspects. For 
example, not all private pharmacies in MENA countries 
maintain patient medication records for prescription or 
non-prescription (Over-The-Counter; OTC)medicines.[14] 
They are not legally or professionally required to do so, 
which makes tracing sale of certain medications difficult. 
Against a pressure to generate income, the temptation to 
exploit those dependent on substances seeking prescription 
medicines to misuse/abuse by selling products at vastly 
inflated prices, becomes apparent.
Pharmacists may however, also be contributing to this 
problem unknowingly, by allowing repeat supply of 
medicines that were legitimately prescribed in the past. 
An example may be a short course of benzodiazepines 
prescribed for anxiety. Repeat supply and prolonged use, 
facilitated by repeat sales, can turn into dependence and an 
inability to cease use. More research is needed to understand 
why pharmacists take it upon themselves to facilitate such 
repeat supply, as it may be more complex than the single 
factor of income generation.
An additional contributing factor to the inappropriate 
supply of prescription/non-prescription medicines is 
lack of training for pharmacists at undergraduate level. In 
many schools of pharmacy, the dependence potential of 
medicines, models of addiction and addiction treatment 
are barely covered in the curriculum. Pharmacists may 
consequently lack confidence in responding to patients 
with an apparent or emerging dependence on prescription 
medicines. This coupled with a lack of referral pathways 
into care may mean persistent supply of medicines fueling 
the development or sustainment of dependence on such 
medicines. People using medicines in a dependent way are 
likely to be at high risk of side effects and may experience 
a lot of harm related to these medicines. Pharmacists are 
well placed in the community to offer advice to such people 
but sadly often lack the skills to identify or respond to such 
concerns. 
Another contributing factor that we have identified in our 
work is the culture and cohesion between people within 
the MENA region of the world. Pharmacists, like others, 
may feel the obligation and desire to help an acquaintance 
or regular patient with their needs (in this case supply 
medicines liable to abuse) despite concerns around 
dependence. Factors such as age, gender, family dynamics, 
job status can all be barriers to refusing to supply a medicine 
if the requestor is perceived to have higher status. This is 
likely to be a very challenging aspect to address.
In summary, the general public think highly of the pharmacy 
profession and seek advice from pharmacists about a 
range of health concerns on a daily basis. Pharmacists 
need to ensure the safe and appropriate use of medicines, 
this is enshrined in codes of ethics across the globe. It is 
however unsurprising that in time of conflict, financial 
crisis, displacement of millions of people and strains on 
natural resources that some members of the public should 
turn to psychoactive substances to relieve their distress and 
trauma. A common source of such psychoactive substances 
includes prescription and non-prescription medicines. This 
makes pharmacists knowingly or unknowingly, dealers in 
such medicines. In order to ‘fix’ this problem, many facets 
need to be addressed. The education of undergraduate 
pharmacy students should include awareness of substance 
dependence and ways in which it can be controlled and 
patients supported. Pharmacists should be able to give 
harm reduction advice and signpost suspected addicts 
to treatment services. The regulation of psychoactive 
medicines needs to be modernized, fit for purpose and 
tightened to ensure supply is traceable and pharmacists 
are accountable for the medicines that they issue. Tighter 
inspection and law enforcement is needed, for example to 
prevent the practice of repeat issuing of medicines against 
a previously spent prescription. In summary, there is a lot 
to do before the pharmacy profession can distance itself 
from being the dealer of many medicines liable to abuse.
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